100
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Development and Characterization of Liposome‐Based Formulation of Amiloride Hydrochloride

, , , , &
Pages 415-420 | Received 01 Feb 2007, Accepted 20 Feb 2007, Published online: 25 Feb 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Saikat Ghosh, Rohan Lalani, Vivek Patel, Subhas Bhowmick & Ambikanandan Misra. (2019) Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities. Expert Opinion on Drug Delivery 16:12, pages 1287-1311.
Read now
Praveen Kumar Gaur, Suresh Purohit, Yatendra Kumar, Shikha Mishra & Anil Bhandari. (2014) Development and characterization of stable nanovesicular carrier for drug delivery. Artificial Cells, Nanomedicine, and Biotechnology 42:5, pages 296-301.
Read now

Articles from other publishers (4)

Mohammad Amin Rajizadeh, Sina Motamedy, Yousof Mir, Faezeh Akhgarandouz, Mohammad Hadi Nematollahi & Akram Nezhadi. (2023) A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms. Journal of Drug Delivery Science and Technology 89, pages 105011.
Crossref
Htet Htet Moe San, Khent Primo Alcantara, Bryan Paul I. Bulatao, Feuangthit Niyamissara Sorasitthiyanukarn, Nonthaneth Nalinratana, Apichart Suksamrarn, Opa Vajragupta, Pranee Rojsitthisak & Pornchai Rojsitthisak. (2022) Folic Acid-Grafted Chitosan-Alginate Nanocapsules as Effective Targeted Nanocarriers for Delivery of Turmeric Oil for Breast Cancer Therapy. Pharmaceutics 15:1, pages 110.
Crossref
Çiğdem Yücel, Zelihagül Değim & Şükran Yilmaz. (2013) Nanoparticle and liposome formulations of doxycycline: Transport properties through Caco-2 cell line and effects on matrix metalloproteinase secretion. Biomedicine & Pharmacotherapy 67:6, pages 459-467.
Crossref
Madaswamy S MuthuSi-Shen Feng. (2009) Pharmaceutical stability aspects of nanomedicines. Nanomedicine 4:8, pages 857-860.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.